Board of Directors


Born 1952. Chairman of the Board and Head of Corporate Development and Marketing. Mr. Austin is a Biologist with a degree from Open University, Buckinghamshire, United Kingdom. Mr. Austin is currently Managing Director of TransformRx. Mr. Austin has previously been Head of Business Development (Pharmaceuticals) F. Hoffmann-LA Roche (1996– 2000), Director European Operations Royalty Funds, Principal in Paul Capital Partners (2000 – 2005). Mr. Austin is currently serving on the Board of Directors in A1M Pharma AB (publ) (Chairman), Algipharma AS (Director) and RSA AG (Director). Mr. Austin has previously been on the Board of Directors in Zestagen AG (Chairman), Machine Intelligence Technologies  Ltd. and MHIG Ltd (Managing Director). Mr. Austin has extensive experience and knowledge of Marketing, Business Development and Financial Investments. In addition, Mr. Austin has taught courses in Pharmaceutical Development in Europe and China.


Born 1942. Director of the Board. Mr. Rudolf has an Engineering degree from the Swiss Federal Institute of Technology in Zürich and has also attended a program for executive  business management at SKU in Switzerland. Mr. Rudolf has previously been Co-owner and Partner of EMESCO AG, a company for restructuring and turnaround management in Zug. In this function Mr. Rudolf turned around a number of companies. Previously he was also CEO of Landis & Gyr Zug AG, an international company manufacturing and marketing electricity meters, Comfort Control Instruments and further equipment for real estates. Afterwards he managed a Landis & Gyr subsidiary in Italy.


Born 1953. Director of the Board. Please see “Senior Management”.